empty

Plan now for 15% spike in AMD cases, researchers warn

Health systems across Europe should start planning now for the significant impact the increasing prevalence of age-related macular degeneration (AMD) will have on healthcare resources, researchers have warned.

Due to ageing populations, an estimated 77 million Europeans will be affected by AMD by 2050 according to a report in the British Journal of Ophthalmology. This represents a 15 per cent increase on current prevalence rates.

The study predicted that one in four adults over 60 in the EU will have AMD by 2050, compared to fewer than one in 10 of those younger than 65. The proportion of over-60s with advanced AMD is expected to be just below 2.5 per cent.

The research team from the University of Bonn in Germany concluded that all European healthcare systems should already be planning for the significant addition to healthcare services required to cope with these projected increases, including the monitoring and treatment of people with advanced disease stages.

Top Stories

NICE fast-tracks epilepsy recommendation

NHS Scotland to commission Hemlibra for haemophilia A



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Network News's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.